Background illustration for clinical trials search

Paid Clinical Trials Seattle

Discover 1,443 paid clinical trials in Seattle, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

for
Schizophrenia, Bipolar I Disorder
Location: Everett WA, Stanford CA, Lincoln NE, Saint Charles MO,
Sponsor: Alkermes, Inc.

Sex: All

Age: 10 - 17

Code: NCT05303064

Phase3, Recruiting

The Measurement of Chemicals in Exhaled Breath Can Identify If a Person is Infected with COVID-19

for
COVID-19
Location: Everett WA
Sponsor: N5 Sensors

Sex: All

Age: 18 - 70

Code: NCT06571136

Recruiting

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

for
Heart Failure NYHA Class II, Heart Failure NYHA Class III,
Location: Everett WA, Portland OR, San Francisco CA,
Sponsor: Endotronix, Inc.

Sex: All

Age: 18+

Code: NCT05934487

Recruiting

Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

for
Major Depressive Disorder
Location: Everett WA, Pico Rivera CA, Orange CA, San Diego CA,
Sponsor: Neurocrine Biosciences

Sex: All

Age: 18+

Code: NCT06786624

Phase3, Recruiting

Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Washington State, SACRED LUNGS Trial

for
Lung Carcinoma
Location: Auburn WA, Shelton WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT07176000

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)

for
Multiple Myeloma, Newly Diagnosed Multiple Myeloma
Location: Puyallup WA, Billings MT, Pasadena CA, Beverly Hills CA,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06679101

Phase3, Recruiting

A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)

for
Bipolar Disorder, Bipolar Depression, Bipolar I Disorder,
Location: Everett WA, Walnut Creek CA, Las Vegas NV,
Sponsor: Xenon Pharmaceuticals Inc.

Sex: All

Age: 18 - 70+

Code: NCT07172516

Phase3, Recruiting

A Trial of the Efficacy and Safety of a Fixed Dose of SEP-363856 in Adults With Generalized Anxiety Disorder

for
Generalized Anxiety Disorder
Location: Everett WA, Redlands CA, Cherry Hill NJ, Jamaica NY,
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.

Sex: All

Age: 18+

Code: NCT07767903

Phase3, Recruiting

A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

for
Major Depressive Disorder
Location: Everett WA, Portland OR, Lafayette CA, Las Vegas NV,
Sponsor: Axsome Therapeutics, Inc.

Sex: All

Age: 18 - 65

Code: NCT06223880

Recruiting

Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder (ASD) in Pediatric Patients

for
Irritability Associated With Autism Spectrum Disorder
Location: Everett WA, Sacramento CA, Sherman Oaks CA, Lincoln NE,
Sponsor: Intra-Cellular Therapies, Inc.

Sex: All

Age: 5 - 17

Code: NCT06706674

Phase3, Recruiting

A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

for
Major Depressive Disorder
Location: Everett WA, Boise ID, Walnut Creek CA, Las Vegas NV,
Sponsor: Xenon Pharmaceuticals Inc.

Sex: All

Age: 18 - 70+

Code: NCT06775379

Phase3, Recruiting

A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)

for
Major Depressive Disorder (MDD),
Location: Everett WA, Glendale CA, San Jose CA, Redlands CA,
Sponsor: Seaport Therapeutics

Sex: All

Age: 18 - 65

Code: NCT07065240

Phase2, Recruiting

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

for
Crohn's Disease, Obesity or Overweight
Location: Tacoma WA, Vancouver, Idaho Falls ID, Northridge CA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70

Code: NCT06937099

Phase3, Recruiting

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

for
Ulcerative Colitis, Obesity or Overweight
Location: Tacoma WA, Vancouver, Idaho Falls ID, Northridge CA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70

Code: NCT06937086

Phase3, Recruiting

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

for
Colitis, Ulcerative
Location: Tacoma WA, Vancouver, Portland OR, Edmonton,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 12+

Code: NCT07196748

Phase3, Recruiting

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

for
Crohn Disease
Location: Tacoma WA, Vancouver, Portland OR, Edmonton,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07196722

Phase2, Phase3, Recruiting

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

for
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate,
Location: Tacoma WA, Portland OR, Spokane WA, Boise ID,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70+

Code: NCT07415044

Phase2, Recruiting

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease

for
Crohn Disease
Location: Tacoma WA, Vancouver, Portland OR, Edmonton,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07577843

Phase3, Recruiting

A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

for
Colitis, Ulcerative
Location: Tacoma WA, Vancouver, Portland OR, Edmonton,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07577856

Phase3, Recruiting

An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

for
Colitis, Ulcerative
Location: Tacoma WA, Los Alamitos CA, Littleton CO, La Jolla CA,
Sponsor: Pfizer

Sex: All

Age: 18 - 64

Code: NCT06398626

Recruiting

As one of the fastest growing cities in America, Seattle stands out as a pivotal location for clinical research. Home to an extensive healthcare network and prominent research institutions, Seattle offers innovative approaches to clinical research and a significant contribution to medical science.

Leading centers such as the Fred Hutchinson Cancer Research Center, the University of Washington Medical Center, and the Seattle Children's Research Institute are at the forefront of groundbreaking studies.

Why choose Seattle for clinical trials?

For those considering participating in a clinical trial, there are several reasons why Seattle is a prime choice. The city is home to a robust network of leading research institutions, which are known for their pioneering work and advanced medical research. Seattle’s collaborative environment and emphasis on innovation enhance the quality and impact of clinical studies.

By participating in a clinical trial in Seattle, you gain access to some of the most advanced research and treatments available, while also contributing to significant medical discoveries. The city's commitment to cutting-edge science and a supportive research infrastructure make it an ideal location for advancing medical knowledge and improving future healthcare outcomes.

Common conditions studied in Seattle

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Seattle